Financial Health Scores: Healthcare

Top Healthcare companies ranked by overall financial health. Each score combines profitability, growth, leverage, liquidity, cash flow, and returns into a single 0-100 rating.

Rates the quality of the business, not whether the stock is cheap. A 0–100 composite of profitability, growth, leverage, liquidity, cash flow, and returns.

A high score means strong fundamentals, but not a guaranteed good trade. A great business can still be a bad buy at the wrong price.

Banks, REITs, insurers, and early-stage companies are scored on sector-tailored metrics. Full methodology →

Research tool, not financial advice. Use alongside valuation analysis and your own view of the business.

Data as of FY 2025 100 companies Rhea AI

# Company Dimensions

UTHR United Therapeutics Co… 89 Profit Growth Debt Cash Flow Return 7/9 Safe 2

CPRX Catalyst Pharmaceutica… Check Earnings 89 Profit Growth Debt Cash Flow Return 4/9 Safe 3

HRMY Harmony Biosciences Ho… 88 Profit Growth Debt Cash Flow Return 5/9 Safe 4

DOCS Doximity, Inc. 88 Profit Growth Debt Cash Flow Return 7/9 Safe 5

RMD ResMed Inc. 87 Profit Growth Debt Cash Flow Return 8/9 Safe 6

FULC Fulcrum Therapeutics, … Emerging Check Earnings 87 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 7

ISRG Intuitive Surgical, In… 86 Profit Growth Debt Cash Flow Return 7/9 Safe 8

IRMD IRADIMED CORPORATION 86 Profit Growth Debt Cash Flow Return 5/9 Safe 9

INVA Innoviva, Inc. Check Earnings Data Issue 83 Profit Growth Debt Cash Flow Return 5/9 Safe 10

ANAB AnaptysBio, Inc. Emerging Check Earnings One-time Loss 83 Cash Dil R&D RevPS Burn BalSh 5/9 Grey 11

STOK Stoke Therapeutics, In… Emerging Check Earnings 82 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 12

CGEN Compugen Ltd. Emerging Check Earnings 82 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 13

LMAT LeMaitre Vascular, Inc… 81 Profit Growth Debt Cash Flow Return 6/9 Safe 14

ADMA ADMA Biologics, Inc. Check Earnings 81 Profit Growth Debt Cash Flow Return 5/9 Safe 15

QTTB Q32 Bio Inc. Emerging Check Earnings Data Issue 80 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 16

NBIX Neurocrine Biosciences… 80 Profit Growth Debt Cash Flow Return 4/9 Safe 17

HNGE Hinge Health, Inc. Emerging Data Issue 80 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 18

EXEL Exelixis, Inc. 80 Profit Growth Debt Cash Flow Return 7/9 Safe 19

UTMD Utah Medical Products,… 79 Profit Growth Debt Cash Flow Return 5/9 Safe 20

SMLR Semler Scientific, Inc… Check Earnings 79 Profit Growth Debt Cash Flow Return 3/9 Safe 21

REGN Regeneron Pharmaceutic… 79 Profit Growth Debt Cash Flow Return 4/9 Safe 22

DCTH Delcath Systems, Inc. Emerging Data Issue 79 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 23

TBPH Theravance Biopharma, … Emerging Data Issue 78 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 24

HALO Halozyme Therapeutics,… 78 Profit Growth Debt Cash Flow Return 5/9 Safe 25

ELMD Electromed, Inc. 78 Profit Growth Debt Cash Flow Return 7/9 Safe 26

CORT Corcept Therapeutics I… 78 Profit Growth Debt Cash Flow Return 4/9 Safe 27

WST West Pharmaceutical Se… 77 Profit Growth Debt Cash Flow Return 7/9 Safe 28

GMED Globus Medical, Inc. 77 Profit Growth Debt Cash Flow Return 7/9 Safe 29

PTGX Protagonist Therapeuti… Emerging 76 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 30

MIRM Mirum Pharmaceuticals,… Emerging 76 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 31

MDXG MiMedx Group, Inc. Data Issue 76 Profit Growth Debt Cash Flow Return 5/9 Safe 32

IDXX IDEXX Laboratories, In… 76 Profit Growth Debt Cash Flow Return 8/9 Safe 33

ARWR Arrowhead Pharmaceutic… Emerging Check Earnings Data Issue 76 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 34

TXG 10x Genomics, Inc. Emerging 75 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 35

PODD Insulet Corporation 75 Profit Growth Debt Cash Flow Return 6/9 Safe 36

ADAG Adagene Inc. Emerging Check Earnings 75 Cash Dil R&D RevPS Burn BalSh 2/9 Distress 37

YMAB Y-mAbs Therapeutics, I… Emerging 74 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 38

VRTX Vertex Pharmaceuticals… 74 Profit Growth Debt Cash Flow Return 6/9 Safe 39

INMD InMode Ltd. 74 Profit Growth Debt Cash Flow Return 3/9 Safe 40

EW Edwards Lifesciences C… 74 Profit Growth Debt Cash Flow Return 6/9 Safe 41

CRON Cronos Group Inc. Emerging Check Earnings 74 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 42

BCRX BioCryst Pharmaceutica… Data Issue 74 Profit Growth Debt Cash Flow Return 7/9 Grey 43

ANIK Anika Therapeutics, In… Emerging 73 Cash Dil R&D RevPS Burn BalSh 5/9 Safe 44

VRCA Verrica Pharmaceutical… Emerging Check Earnings Data Issue 72 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 45

UFPT UFP Technologies, Inc. 72 Profit Growth Debt Cash Flow Return 7/9 Safe 46

TCMD Tactile Systems Techno… 72 Profit Growth Debt Cash Flow Return 7/9 Safe 47

NNNN Anbio Biotechnology Check Earnings Data Issue 72 Profit Growth Debt Cash Flow Return 4/9 Safe 48

LNTH Lantheus Holdings, Inc… Check Earnings 72 Profit Growth Debt Cash Flow Return 5/9 Safe 49

BMRN BioMarin Pharmaceutica… 72 Profit Growth Debt Cash Flow Return 4/9 Safe 50

WAT Waters Corporation 71 Profit Growth Debt Cash Flow Return 4/9 Safe 51

SRDX Surmodics, Inc. Emerging 71 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 52

LGND Ligand Pharmaceuticals… 71 Profit Growth Debt Cash Flow Return 4/9 Safe 53

IDYA IDEAYA Biosciences, In… Emerging Check Earnings 71 Cash Dil R&D RevPS Burn BalSh 3/9 Safe 54

SNOA Sonoma Pharmaceuticals… Emerging 70 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 55

PGNY Progyny, Inc. 70 Profit Growth Debt Cash Flow Return 5/9 Safe 56

KRMD KORU Medical Systems, … Emerging 70 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 57

DXCM DexCom, Inc. 70 Profit Growth Debt Cash Flow Return 7/9 Safe 58

ANIP ANI Pharmaceuticals, I… 70 Profit Growth Debt Cash Flow Return 7/9 Grey 59

AMPH Amphastar Pharmaceutic… 70 Profit Growth Debt Cash Flow Return 6/9 Grey 60

ABT Abbott Laboratories 70 Profit Growth Debt Cash Flow Return 5/9 Safe 61

XOMA XOMA Royalty Corporati… Emerging 69 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 62

VCYT Veracyte, Inc. 69 Profit Growth Debt Cash Flow Return 7/9 Safe 63

TVTX Travere Therapeutics, … Emerging Check Earnings Unit Sold 69 Cash Dil R&D RevPS Burn BalSh 6/9 Grey 64

SLGL Sol-Gel Technologies L… Emerging Check Earnings 69 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 65

RGEN Repligen Corporation 69 Profit Growth Debt Cash Flow Return 7/9 Safe 66

PULM Pulmatrix, Inc. Emerging Check Earnings 69 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 67

PEN Penumbra, Inc. 69 Profit Growth Debt Cash Flow Return 6/9 Safe 68

PBYI Puma Biotechnology, In… Check Earnings Data Issue 69 Profit Growth Debt Cash Flow Return 7/9 Distress 69

MMSI Merit Medical Systems,… 69 Profit Growth Debt Cash Flow Return 7/9 Safe 70

KURA Kura Oncology, Inc. Check Earnings New Filer 69 Profit Growth Debt Cash Flow Return 2/9 Distress 71

HQY HealthEquity, Inc. 69 Profit Growth Debt Cash Flow Return 8/9 Safe 72

HOLX Hologic, Inc. 69 Profit Growth Debt Cash Flow Return 5/9 Safe 73

BLFS BioLife Solutions, Inc… Emerging Unit Sold 69 Cash Dil R&D RevPS Burn BalSh 6/9 Safe 74

ADUS Addus HomeCare Corpora… 69 Profit Growth Debt Cash Flow Return 7/9 Safe 75

ACAD ACADIA Pharmaceuticals… Check Earnings 69 Profit Growth Debt Cash Flow Return 5/9 Safe 76

ROIV Roivant Sciences Ltd. Emerging Check Earnings Unit Sold 68 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 77

NMTC NeuroOne Medical Techn… Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 78

NHC National HealthCare Co… 68 Profit Growth Debt Cash Flow Return 7/9 Safe 79

LXRX Lexicon Pharmaceutical… Emerging Check Earnings Data Issue 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 80

CUE Cue Biopharma, Inc. Emerging Check Earnings 68 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 81

ALKS Alkermes plc 68 Profit Growth Debt Cash Flow Return 5/9 Safe 82

ZYME Zymeworks Inc. Emerging 67 Cash Dil R&D RevPS Burn BalSh 4/9 Safe 83

ZVRA Zevra Therapeutics, In… Emerging Check Earnings 67 Cash Dil R&D RevPS Burn BalSh 6/9 Distress 84

ZLAB Zai Lab Limited Emerging 67 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 85

XBIO Xenetic Biosciences, I… Emerging Data Issue 67 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 86

TECH Bio-Techne Corporation 67 Profit Growth Debt Cash Flow Return 5/9 Safe 87

SYK Stryker Corporation 67 Profit Growth Debt Cash Flow Return 4/9 Safe 88

SPRO Spero Therapeutics, In… Emerging Check Earnings Data Issue 67 Cash Dil R&D RevPS Burn BalSh 4/9 Grey 89

KYNB Kyntra Bio, Inc. Emerging Check Earnings Data Issue 67 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 90

FGEN FibroGen, Inc. Emerging Check Earnings Data Issue 67 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 91

ARVN Arvinas, Inc. Emerging Check Earnings 67 Cash Dil R&D RevPS Burn BalSh 4/9 Distress 92

VMD Viemed Healthcare, Inc… 66 Profit Growth Debt Cash Flow Return 6/9 Safe 93

QGEN Qiagen N.V. 66 Profit Growth Debt Cash Flow Return 7/9 Safe 94

NAMS NewAmsterdam Pharma Co… Emerging 66 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 95

MRSN Mersana Therapeutics, … Emerging Check Earnings Data Issue 66 Cash Dil R&D RevPS Burn BalSh 4/9 - 96

MASI Masimo Corporation One-time Loss Unit Sold 66 Profit Growth Debt Cash Flow Return 7/9 Safe 97

IMCR Immunocore Holdings pl… Emerging 66 Cash Dil R&D RevPS Burn BalSh 3/9 Distress 98

COYA Coya Therapeutics, Inc… Emerging Data Issue 66 Cash Dil R&D RevPS Burn BalSh 2/9 Safe 99

TXMD TherapeuticsMD, Inc. Emerging Check Earnings Data Issue 65 Cash Dil R&D RevPS Burn BalSh 5/9 Distress 100

KNSA Kiniksa Pharmaceutical… 65 Profit Growth Debt Cash Flow Return 7/9 Safe

How the Financial Health Score is calculated

Each company receives a composite score from 0 to 100 based on six financial dimensions derived from annual SEC filings: Profitability, Growth, Leverage, Liquidity, Cash Flow, and Returns. Each dimension is normalized to a 0 to 100 scale; the overall score is the simple average of all six (missing dimensions count as zero, so incomplete data can't inflate a ranking).

Trailing 3-year weighted average for the performance-oriented dimensions (Profitability, Cash Flow, Returns). The most recent fiscal year is weighted 50%, the year before 30%, and the year before that 20%, so a company still gets credit for improving quickly, but a single blockbuster year can't carry an otherwise weak record.
Growth uses a 3-year revenue CAGR (or year-over-year if only two years are available), so sustained growth beats one lucky quarter.
Leverage and Liquidity are balance-sheet snapshots, using the most recent available value and falling back to the prior year when a newly filed 10-K is missing a field.
Companies with fewer than three years of filings are scored on what's available. No minimum history is required, but the missing years count as zero in the flow-metric averages.
Warrants, preferred shares and duplicate listings that share a parent company's financials are automatically filtered from the ranking.

The Piotroski F-Score (0 to 9) measures fundamental strength using nine binary accounting tests; the Altman Z-Score estimates bankruptcy risk, classifying companies into Safe, Grey, or Distress zones. These two signals are shown alongside the composite score for additional perspective.